Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000433329 | SCV000528693 | uncertain significance | not provided | 2024-02-06 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 32979048) |
Fulgent Genetics, |
RCV000765979 | SCV000897402 | uncertain significance | Hereditary spastic paraplegia 50 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000765979 | SCV000957339 | uncertain significance | Hereditary spastic paraplegia 50 | 2024-01-25 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 367 of the AP4M1 protein (p.Arg367Gln). This variant is present in population databases (rs139861201, gnomAD 0.05%). This missense change has been observed in individual(s) with hereditary spastic paraplegia (PMID: 32979048). ClinVar contains an entry for this variant (Variation ID: 386884). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt AP4M1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ce |
RCV000433329 | SCV002062764 | uncertain significance | not provided | 2021-12-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001848781 | SCV002105673 | uncertain significance | Hereditary spastic paraplegia | 2021-11-15 | criteria provided, single submitter | clinical testing | |
Yale Center for Mendelian Genomics, |
RCV001849371 | SCV002106881 | likely pathogenic | Spastic paraplegia | 2020-10-01 | no assertion criteria provided | literature only |